Clinical Decision Support Systems Market Consumption Sales By Type, Product Specifications, Research Methodology, Forecast

SDKI Inc. published a new report on the clinical decision support system (CDSS) market. This study includes the statistical and analytical approaches needed to grow the CDSS market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-109520

The clinical decision support system market is estimated to grow from a market value of US $ 1,400.07 million in 2022 to US $ 3,056.63 million by 2030, with a CAGR of 11.8% during the forecast period.

Market growth is driven primarily by government support and initiatives to facilitate the adoption of HCIT solutions in healthcare, and increased rates of malpractice. Increasing attention and utilization of big data and medical tools, increasing adoption of cloud computing in healthcare, and partnerships between medical research groups and clinical decision-supporting companies are also driving market growth. That is the factor. However, they are reluctant to adopt mobile CDSS, and heavy investment in IT infrastructure, data security concerns associated with cloud-based CDSS, and lack of interoperability could curb market growth. I have.

Market segment

The clinical decision support system market is by component (service, software), distribution mode (on-premises, cloud-based), product (integrated CDSS, stand-alone CDSS), application (advanced CDSS, conventional CDSS), It is divided by model (knowledge-based, non-knowledge-based), type (treatment, diagnosis), bidirectional (active, passive), patient care settings and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Based on the application, the traditional CDSS segment dominated the market in 2017.

Based on the application, the market is divided into traditional CDSS and advanced CDSS. In 2017, the traditional CDSS segment had the largest share of the global CDSS market. However, the advanced CDSS segment is estimated to grow at the fastest rate during the forecast period. This is because these systems perform additional functions such as population health management, financial decision support, real-time evidence-based decision making, treatment planning, and clinician assistance in protocol validation.

The integrated CDSS segment is expected to grow at a maximum CAGR during the forecast period.

Based on the product, the CDSS market is divided into integrated CDSS and standalone CDSS. The integrated CDSS segment had the largest market share in 2017. The large share of this segment is primarily due to the growing rollout of integrated CDSS. Integrated CDSS is widely used by healthcare providers to improve quality of care and health and reduce medical malpractice. While using the integrated solution, users can easily switch from one type of application to another without exiting the program.

Area overview

The North American region occupies the largest share of the global clinical decision support system market in 2017, followed by Europe, Asia Pacific and other regions (RoW). However, the Asia Pacific region is expected to grow at a maximum CAGR during the 2022-2030 forecast period. Factors such as the presence of a large patient population demanding lower cost and better medical care, economic growth, and the implementation of favorable government policies are driving market growth in the region. In addition, increased spending on IT infrastructure by healthcare providers and increased attention from various market players to emerging Asian countries are expected to drive market growth in the region.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, and other Asia Pacific); Latin America (Brazil, Mexico, Argentina, and other Latin). USA); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy, Spain) , Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

Major key players on the market

Key players in the clinical decision support system market include Cerner Corporation (US), McKesson Corporation (US), Epic Systems Corporation Inc. (US), Medical Information Technology, Inc. (US), and Philips Healthcare (Netherlands). , Allscripts Healthcare Solutions, Inc. (USA), Wolters Kluwer Health (USA), Hearst Health (USA), Elsevier BV (Netherlands), International Business Machines (IBM) Corporation (USA). The study includes in-depth competitive analysis, corporate profiles, recent developments, and key market strategies for these key companies in the clinical decision support system market.

Details of the survey report
https://www.sdki.jp/reports/clinical-decision-support-systems-market/109520

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.